Tourmaline Bio, Inc.

TRML · NASDAQ
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Assets
Cash & Equivalents$31,423$35,330$30,506$35,008
Short-Term Investments$207,811$213,976$227,797$246,916
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$9,867$8,838$10,539$11,861
Total Curr. Assets$249,101$258,144$268,842$293,785
Property Plant & Equip (Net)$174$229$267$307
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$17,184$26,000$36,633$32,467
Tax Assets$0$0$0$0
Other NC Assets$2,836$3,125$3,259$1,888
Total NC Assets$20,194$29,354$40,159$34,662
Other Assets$0$0$0$0
Total Assets$269,295$287,498$309,001$328,447
Liabilities
Payables$3,170$2,235$3,583$2,054
Short-Term Debt$145$196$227$226
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$6,780$5,191$5,099$5,004
Total Curr. Liab.$10,095$7,622$8,909$7,284
LT Debt$0$0$17$64
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$8$13$23$31
Total NC Liab.$8$13$40$95
Other Liabilities$0$0$0$0
Cap. Leases$145$196$244$290
Total Liabilities$10,103$7,635$8,949$7,379
Equity
Pref Stock$0$0$0$0
Common Stock$3$3$3$3
Retained Earnings-$181,323-$158,231-$135,261-$113,026
AOCI$121$227$296$821
Other Equity$440,391$437,864$435,014$433,270
Total Equity$259,192$279,863$300,052$321,068
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$269,295$287,498$309,001$328,447
Net Debt-$31,278-$35,134-$30,262-$34,718